Free Trial
OTCMKTS:XSNX

NovAccess Global (XSNX) Stock Price, News & Analysis

NovAccess Global logo
$0.0003 0.00 (0.00%)
As of 06/20/2025

About NovAccess Global Stock (OTCMKTS:XSNX)

Key Stats

Today's Range
$0.0003
$0.0003
50-Day Range
N/A
52-Week Range
$0.0001
$0.0190
Volume
1 shs
Average Volume
5,224 shs
Market Capitalization
$13.38 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. The company was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.

Receive XSNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NovAccess Global and its competitors with MarketBeat's FREE daily newsletter.

XSNX Stock News Headlines

Global wage calculator: Compare your salary
NovAccess Global Inc.
When This Happens, You Don’t Wait. You Act.
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
NovAccess Global Inc. (XSNX)
See More Headlines

XSNX Stock Analysis - Frequently Asked Questions

NovAccess Global's stock was trading at $0.01 at the start of the year. Since then, XSNX stock has decreased by 97.0% and is now trading at $0.0003.
View the best growth stocks for 2025 here
.

Shares of XSNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that NovAccess Global investors own include Co-Diagnostics (CODX), iBio (IBIO), Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), T2 Biosystems (TTOO), Kopin (KOPN) and Adamis Pharmaceuticals (ADMP).

Company Calendar

Today
6/21/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:XSNX
Employees
2
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
($0.58) per share
Price / Book
0.00

Miscellaneous

Free Float
43,961,000
Market Cap
$13.38 thousand
Optionable
Not Optionable
Beta
3.32
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (OTCMKTS:XSNX) was last updated on 6/21/2025 by MarketBeat.com Staff
From Our Partners